Waxman Bill Would Alter OTC Ad Rules, Streamline FDA Monograph Authority
This article was originally published in The Rose Sheet
Executive Summary
Personal-care products regulated under over-the-counter drug monographs would be subject to significantly increased FDA authority and more complex advertising regulations under a bill introduced by Democrats Nov. 6